PARIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has expanded its existing partnership with Institute of Isotopes Co. Ltd. (Izotop) to make ...
PARIS, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, announced today that it has expanded its existing partnership with Institute of Isotopes Co. Ltd. (Izotop ...
Curium, a world leader in nuclear medicine, announced that Pylclari is now available for patients with prostate cancer in Estonia, Finland, Latvia, and Sweden. Pylclari (INN: Piflufolastat (18F) also ...
PARIS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, today announced that in Estonia, Finland, Latvia, and Sweden, PYLCLARI® is now available for patients with ...
PYLCLARI ® is being produced by Curium at its facilities in Helsinki, Finland – ensuring distribution to Estonia, Finland, Latvia, and Sweden. For more information about PYLCLARI ®: www.pylclari.com ...
The agreement also includes a strategic contract manufacturing agreement appointing Curium as the manufacturer of the product for Telix. Kevin Richardson, Chief Executive Officer, Telix Precision ...
Today will see any fog clear early on, but cloudy skies will remain again, with only a few rare bright breaks. Another dry, mild and settled day. Tonight Tonight will remain largely cloudy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback